Clinical Trial Update: Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More [Phase 3]

View source ↗

Summary

Phase 3 trial on triple-dose tuberculosis retreatment regimens was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Pulmonary

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Tuberculosis, Pulmonary | Phase 3 | Status: WITHDRAWN